Novo Nordisk A/S: dividend

NVONYSEHealthcare · Pharmaceutical Preparations

Price

$40.70

November 17, 2026Market cap $181B

What Ploutos Investor adds for Novo Nordisk A/S

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2019
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Yield

4.52%

$1.84 per share over the last 12 months, at a price of $40.70.

FCF coverThe year's free cash flow was 1.1 times the dividend it paid.
1.1x
Payout51% of the last 12 months' earnings went to the dividend.
51%
No cutWithout a cut since 2019, the first year of our figures: the run may be longer.
6+
5-year growthAverage yearly growth over the last five years.
+19.7%
Debt / EBITDAMoney that goes to interest does not go to the dividend.
0.8x

The dividend year by year

What it paid per share each fiscal year, how much that changed, and the yield it gave at the price at year end.

+19.7% a year over 5 years
  • 2025
    Dividend per share$1.84
  • 2024
    Dividend per share$1.58
  • 2023
    Dividend per share$1.39

Each fiscal year's dividend as the company states it in its filings, adjusted for stock splits. Special dividends count in the year they were paid.

The dividend year by year

NVO's dividend per share each fiscal year, from 2019 to 2022, 4 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Everything it returns to shareholders

The dividend is one way. The other is buybacks, which reduce the number of shares.

Dividend yield

4.52%

$45.20 a year per $1,000 of shares

Buybacks

0.12%

$1.20 a year per $1,000 of shares

The share count rose by 0.1% over the year, so more shares were issued than bought back.

Total returned

4.64%

$46.40 a year per $1,000 of shares

dividend 97%buybacks 3%

The full analysis

What do Novo Nordisk A/S's filings show?

The dividend is one part of Novo Nordisk A/S's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about NVO's dividend

Didn't find what you were looking for?

Ask us
What is NVO's dividend yield?

Novo Nordisk A/S paid $1.84 per share over the last 12 months. At a price of $40.70, that is a yield of 4.52%.

Does NVO cover its dividend with the cash it makes?

Yes, over the last year. Novo Nordisk A/S's free cash flow was 1.1 times the dividend it paid.

Has NVO ever cut its dividend?

Novo Nordisk A/S has not cut its dividend for 6+ years, in the 7 years of figures we hold.

How much has NVO's dividend grown?

Novo Nordisk A/S's dividend per share changed by +19.7% a year on average over the last five years.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.